The closing price of Aurora Innovation Inc (NASDAQ: AUR) was $3.00 for the day, down -2.28% from the previous closing price of $3.07. On the day, 5702320 shares were traded.
Ratios:
Our analysis of AUR’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 10.96 and its Current Ratio is at 10.96. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Goldman on January 03, 2024, Downgraded its rating to Sell and sets its target price to $2 from $1.75 previously.
On September 19, 2023, TD Cowen started tracking the stock assigning a Market Perform rating and target price of $3.
On September 12, 2023, Evercore ISI started tracking the stock assigning a In-line rating and target price of $4.Evercore ISI initiated its In-line rating on September 12, 2023, with a $4 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 01 ’24 when Hoffman Reid sold 80,000 shares for $2.59 per share. The transaction valued at 207,440 led to the insider holds 459,563 shares of the business.
Hoffman Reid sold 1,000,000 shares of AUR for $2,521,500 on Feb 29 ’24. The Director now owns 463,563 shares after completing the transaction at $2.52 per share. On Feb 28 ’24, another insider, Hoffman Reid, who serves as the Director of the company, sold 2,700,000 shares for $2.52 each. As a result, the insider received 6,798,600 and left with 513,563 shares of the company.
Stock Price History:
Over the past 52 weeks, AUR has reached a high of $4.81, while it has fallen to a 52-week low of $1.28.
Shares Statistics:
A total of 1.16B shares are outstanding, with a floating share count of 727.14M. Insiders hold about 53.06% of the company’s shares, while institutions hold 40.18% stake in the company.
Earnings Estimates
The firm’s stock currently is rated by Aurora Cannabis Inc. analysts. The consensus estimate for the next quarter is $5.04, with high estimates of $17.82 and low estimates of $12.18.
Analysts are recommending an EPS of between $Real Estate and $Real Estate for the fiscal current year, implying an average EPS of $Healthcare.
